File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/adhm.202002202
- Scopus: eid_2-s2.0-85104977719
- PMID: 33943037
- Find via

Supplementary
- Citations:
- Appears in Collections:
Article: Well-Defined Nanostructured Biointerfaces: Strengthened Cellular Interaction for Circulating Tumor Cells Isolation
| Title | Well-Defined Nanostructured Biointerfaces: Strengthened Cellular Interaction for Circulating Tumor Cells Isolation |
|---|---|
| Authors | |
| Keywords | biospecific capture circulating tumor cells integrated biointerfaces reversible release |
| Issue Date | 2021 |
| Citation | Advanced Healthcare Materials, 2021, v. 10, n. 11, article no. 2002202 How to Cite? |
| Abstract | The topographic features at the cell–material biointerface are critical for cellular sensing of the extracellular environment (ECM) and have gradually been recognized as key factors that regulate cell adhesion behavior. Herein, a well-defined nanostructured biointerface is fabricated via a new generation of mussel-inspired polymer coating to mimic the native ECM structures. Upon the bioinert background presence and biospecific ligands conjugation, the affinity of cancer cells to the resulting biofunctional surfaces, which integrate topographic features and biochemical cues, is greatly strengthened. Both the conjugated bioligand density, filopodia formation, and focal adhesion expression are significantly enhanced by the surficial nano-features with an optimized size-scale. Thus, this nanostructured biointerface exhibits high capture efficiency for circulating tumor cells (CTCs) with high sensitivity, high biospecificity, and high purity. Benefiting from the unique bioligands conjugation chemistry herein, the captured cancer cells can be responsively detached from the biointerfaces without damage for downstream analysis. The present biofunctional nanostructured interfaces offer a good solution to address current challenges to efficiently isolate rare CTCs from blood samples for earlier cancer diagnosis. |
| Persistent Identifier | http://hdl.handle.net/10722/368050 |
| ISSN | 2023 Impact Factor: 10.0 2023 SCImago Journal Rankings: 2.337 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yu, Leixiao | - |
| dc.contributor.author | Tang, Peng | - |
| dc.contributor.author | Nie, Chuanxiong | - |
| dc.contributor.author | Hou, Yong | - |
| dc.contributor.author | Haag, Rainer | - |
| dc.date.accessioned | 2025-12-19T08:01:30Z | - |
| dc.date.available | 2025-12-19T08:01:30Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Advanced Healthcare Materials, 2021, v. 10, n. 11, article no. 2002202 | - |
| dc.identifier.issn | 2192-2640 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/368050 | - |
| dc.description.abstract | The topographic features at the cell–material biointerface are critical for cellular sensing of the extracellular environment (ECM) and have gradually been recognized as key factors that regulate cell adhesion behavior. Herein, a well-defined nanostructured biointerface is fabricated via a new generation of mussel-inspired polymer coating to mimic the native ECM structures. Upon the bioinert background presence and biospecific ligands conjugation, the affinity of cancer cells to the resulting biofunctional surfaces, which integrate topographic features and biochemical cues, is greatly strengthened. Both the conjugated bioligand density, filopodia formation, and focal adhesion expression are significantly enhanced by the surficial nano-features with an optimized size-scale. Thus, this nanostructured biointerface exhibits high capture efficiency for circulating tumor cells (CTCs) with high sensitivity, high biospecificity, and high purity. Benefiting from the unique bioligands conjugation chemistry herein, the captured cancer cells can be responsively detached from the biointerfaces without damage for downstream analysis. The present biofunctional nanostructured interfaces offer a good solution to address current challenges to efficiently isolate rare CTCs from blood samples for earlier cancer diagnosis. | - |
| dc.language | eng | - |
| dc.relation.ispartof | Advanced Healthcare Materials | - |
| dc.subject | biospecific capture | - |
| dc.subject | circulating tumor cells | - |
| dc.subject | integrated biointerfaces | - |
| dc.subject | reversible release | - |
| dc.title | Well-Defined Nanostructured Biointerfaces: Strengthened Cellular Interaction for Circulating Tumor Cells Isolation | - |
| dc.type | Article | - |
| dc.description.nature | link_to_subscribed_fulltext | - |
| dc.identifier.doi | 10.1002/adhm.202002202 | - |
| dc.identifier.pmid | 33943037 | - |
| dc.identifier.scopus | eid_2-s2.0-85104977719 | - |
| dc.identifier.volume | 10 | - |
| dc.identifier.issue | 11 | - |
| dc.identifier.spage | article no. 2002202 | - |
| dc.identifier.epage | article no. 2002202 | - |
| dc.identifier.eissn | 2192-2659 | - |
